🇺🇸 FDA
Patent

US 7763637

Quinolinone-carboxamide compounds as 5-HT4, receptor agonists

granted A61PA61P1/00A61P1/04

Quick answer

US patent 7763637 (Quinolinone-carboxamide compounds as 5-HT4, receptor agonists) held by Theravance, Inc. expires Mon Jul 22 2030 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Theravance, Inc.
Grant date
Tue Jul 27 2010 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jul 22 2030 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
19
CPC classes
A61P, A61P1/00, A61P1/04, A61P1/10, A61P1/14